CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Planned sale Chief Financial Officer sold 90,000 shares at $15.78 ($1,419,759)
- 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
- 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
- 4 Open-market buy Director bought 10,857 shares at $9.30 ($100,958)
- 4 Open-market sale General Counsel sold 8,497 shares at $10.50 ($89,219)
- 4 Open-market sale Chief Scientific Officer sold 172,585 shares at $9.33 ($1,610,097)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Financial Officer acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Business Officer sold 1,747 shares at $8.90 ($15,557)
Page 6 of 11 · 203 filings